X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES TORRENT PHARMA JUBILANT LIFE SCIENCES/
TORRENT PHARMA
 
P/E (TTM) x 15.7 45.6 34.3% View Chart
P/BV x 4.6 6.2 74.6% View Chart
Dividend Yield % 0.4 0.8 47.6%  

Financials

 JUBILANT LIFE SCIENCES   TORRENT PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
TORRENT PHARMA
Mar-18
JUBILANT LIFE SCIENCES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1871,550 12.1%   
Low Rs651,144 5.7%   
Sales per share (Unadj.) Rs364.3354.7 102.7%  
Earnings per share (Unadj.) Rs6.840.1 17.1%  
Cash flow per share (Unadj.) Rs24.564.2 38.1%  
Dividends per share (Unadj.) Rs3.0014.00 21.4%  
Dividend yield (eoy) %2.41.0 229.1%  
Book value per share (Unadj.) Rs164.9273.1 60.4%  
Shares outstanding (eoy) m159.28169.22 94.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.8 9.1%   
Avg P/E ratio x18.433.6 54.7%  
P/CF ratio (eoy) x5.121.0 24.5%  
Price / Book Value ratio x0.84.9 15.5%  
Dividend payout %43.834.9 125.4%   
Avg Mkt Cap Rs m20,061227,897 8.8%   
No. of employees `0006.214.7 42.1%   
Total wages/salary Rs m11,05211,353 97.4%   
Avg. sales/employee Rs Th9,383.04,083.0 229.8%   
Avg. wages/employee Rs Th1,786.9772.3 231.4%   
Avg. net profit/employee Rs Th176.3461.3 38.2%   
INCOME DATA
Net Sales Rs m58,03460,021 96.7%  
Other income Rs m1912,988 6.4%   
Total revenues Rs m58,22463,009 92.4%   
Gross profit Rs m5,78613,493 42.9%  
Depreciation Rs m2,8124,086 68.8%   
Interest Rs m3,2373,085 104.9%   
Profit before tax Rs m-729,310 -0.8%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6962,529 27.5%   
Profit after tax Rs m1,0906,781 16.1%  
Gross profit margin %10.022.5 44.4%  
Effective tax rate %-965.927.2 -3,556.2%   
Net profit margin %1.911.3 16.6%  
BALANCE SHEET DATA
Current assets Rs m29,28052,623 55.6%   
Current liabilities Rs m38,91252,022 74.8%   
Net working cap to sales %-16.61.0 -1,656.0%  
Current ratio x0.81.0 74.4%  
Inventory Days Days84120 70.6%  
Debtors Days Days5176 66.5%  
Net fixed assets Rs m55,71285,016 65.5%   
Share capital Rs m155846 18.3%   
"Free" reserves Rs m20,96845,376 46.2%   
Net worth Rs m26,26546,222 56.8%   
Long term debt Rs m17,16941,115 41.8%   
Total assets Rs m88,606142,432 62.2%  
Interest coverage x1.04.0 24.3%   
Debt to equity ratio x0.70.9 73.5%  
Sales to assets ratio x0.70.4 155.4%   
Return on assets %4.96.9 70.5%  
Return on equity %4.214.7 28.3%  
Return on capital %11.614.2 81.5%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00414,580 150.9%   
Fx outflow Rs m11,7493,600 326.4%   
Net fx Rs m10,25510,980 93.4%   
CASH FLOW
From Operations Rs m8,0268,942 89.8%  
From Investments Rs m-1,744-47,070 3.7%  
From Financial Activity Rs m-4,44734,174 -13.0%  
Net Cashflow Rs m1,834-3,655 -50.2%  

Share Holding

Indian Promoters % 45.6 71.5 63.8%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 7.0 123.9%  
FIIs % 21.2 12.6 168.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 8.8 239.8%  
Shareholders   23,815 26,511 89.8%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PLETHICO PHARMA  BIOCON LTD  J.B.CHEMICALS  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 450 Points Down; All Eyes on State Election Results & Urjit Patel's Resignation(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.1% while the Hang Seng is also up 0.1%.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY19); Net Profit Up 67.2% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 67.2% YoY). Sales on the other hand came in at Rs 23 bn (up 38.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Dec 11, 2018 12:43 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - NOVARTIS COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS